SUMMARY The presence of leucocyte migration inhibition factor (LIF) in supernatants from apparently antigen-and mitogen-free cultures of mononuclear cells (MNC) was studied. MNC were eluted from inflamed synovial tissue or isolated from blood. Untreated supernatants, supernatants in which any LIF had been inactivated, and culture medium were compared in their ability to affect the migration of homologous polymorphonuclear leucocytes. LIF was released by synovial tissue MNC from all of the 9 patients studied, consisting of 5 patients with rheumatoid arthritis, 2 with psoriatic arthropathy, and 2 with juvenile rheumatoid arthritis. Blood MNC of the patients and of 8 healthy blood donors did not release LIF. When synovial tissue MNC supernatants from 2 patients were examined, LIF activity increased as time of incubation was extended. In at least 2 synovial tissue MNC supernatants in which LIF had been inactivated a migration enhancement activity was revealed.
The inflamed synovial membrane of rheumatoid arthritis (RA) is heavily populated by lymphocytes, macrophage-like cells,1 immunoglobulin-containing plasma cells,2 and occasionally polymorphonuclear leucocytes (PML).3 Infiltrating cells are responsible for local immune responses, such as the production of large amounts of immunoglobulins4 and the release of lymphokines as macrophage migration inhibition factor (MIF) and lymphocyte mitogenic factor.5
Leucocyte migration inhibition factor (LIF) is a lymphokine which inhibits the migration of PML in vitro.6 LIF is produced by sensitised lymphocytes in response to antigens or mitogens.7 However, there are reports of apparently antigen-and mitogenfree incubation conditions in which LIF 100 ,ig/ml of NaHCO3, 100 IU/ml penicilline, and 100 ±ug/ml streptomycin in Medium 199. 4 The mean MI1 of 9 supernatants from the cultures of synovial tissue MNC was 0 83 ±0 04 (mean ±SD), which was significantly lower than the mean MI1 of 8 normal blood MNC supernatants of 0-99±0-06 (p<O*00l, Table 1 ). The normal range of MI1 of normal blood MNC supernatants (mean ± 2 SD) was 0 87-1 11, and all MI1 of the synovial tissue MNC supernatants were at or below this range (Fig.  1) 1-32, respectively) . The other MI3 were within or at the normal range limit of normal blood When MI3 and also MI2 were examined ( On the whole after 3-5 days of synovial tissue MNC incubation the supernatant seemed to contain activities capable of affecting the migration of homologous PML in both an inhibitory and a stimulatory way.
As the time of synovial tissue MNC incubation passed 24, 28, and 96 h, the supernatant of patient 7 gradually increased in LIF activity (decreased MI1, Fig. 2 ). When we tested the supernatant after 96 h of incubation no enhancement activity was recovered (low MI2 and MI3).
As controls supernatants of blood MNC from 2 healthy individuals were also studied in the same way. Fig. 2 shows that even after a long period of incubation their supernatants did not show any activity inhibiting or stimulating PML migration.
EFFECT OF OPERATION ON BLOOD MNC
Blood MNC from 3 female patients with RA were _eparMed 1 day before and I day after the operation.
Asr n72 hour of incubation neither MNC taken Table 2 it is clear that there was no correlation between the patients' titre of rheumatoid factor and the presence of LIF (or LEF). In addition, the drugs that were used did not seem to affect the release of LIF (or LEF).
Discussion
In the 9 patients studied LIF was found in the supernatants of all cultures of eluted synovial tissue MNC. The cells were not exposed to any known in-vitro stimulation of antigens or mitogens. Super We have also showed that the patients' blood MNC did not release LIF under the same antigenand mitogen-free culture conditions but rather behaved in the same way as blood MNC from healthy individuals. Hence there seems to be a basic difference between the conditions of the infiltrating and circulating MNC, which might indicate that RA and related arthritides are maintained by pathological agents localised in the joint tissue.
Since blood MNC samples for practical reasons had to be isolated from samples drawn 1 or a few days after the operation, the behaviour of blood MNC might have been influenced by the postoperative state. However, results on blood MNC from 3 patients with RA obtained 1 day before and 1 day after the synovectomy showed no LIF release. Neither the operation, nor anaesthesia, nor the drugs that were used (prednisone, gold thiomalate, and anti-inflammatory drugs) set off LIF release from their blood MNC.
The above-mentioned PML migration enhancement activity of some of the synovial tissue MNC LIC-inactivated supernatants was never seen in blood MNC supernatants. Until LEF is better characterised it is difficult to interpret the observed migration stimulation. 
